Drug
Kur 502
Kur 502: highest development phase Phase 1, developed by Athenex. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Athenex
Trials
| Drug | Phase | Indication |
|---|---|---|
| KUR-502 NCT05487651 | Phase 1 | NHL, Relapsed, Adult |
Latest
No recent events.
Follow Kur 502 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.